Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
NCT01315236 is registered in ClinicalTrials.gov with Insmed Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease
- Lead sponsor
- Insmed Incorporated
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 19, 2012
- Completion date
- June 18, 2015
- Enrollment
- 90 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.